In vivo induction of type 1-like regulatory T cells using genetically modified B cells confers long-term IL-10-dependent antigen-specific unresponsiveness

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 8232-8243

  Ahangarani, Roxana Roohi ^a   Janssens, Wim ^a   VanderElst, Luc ^a   Carlier, Vincent ^a   VandenDriessche, Thierry ^b   Chuah, Marinee ^b   Weynand, Birgit ^c   Vanoirbeek, Jeroen A J ^b   Jacquemin, Marc ^a   Saint Remy, Jean Marie ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSFORMING GROWTH FACTOR BETA; EPITOPE;

ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CELL TRANSFER; CONTROLLED STUDY; GENE SEQUENCE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMAL; ASTHMA; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; FEMALE; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE MUTANT; MURINE LEUKEMIA VIRUS; PHYSIOLOGY; TRANSGENIC MOUSE; TRANSPLANTATION;

ADOPTIVE TRANSFER; AMINO ACID SEQUENCE; ANIMALS; ASTHMA; B-LYMPHOCYTE SUBSETS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNE TOLERANCE; INTERLEUKIN-10; LEUKEMIA VIRUS, MURINE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, REGULATORY; TRANSDUCTION, GENETIC;

EID: 76249132172     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901777     Document Type: Article

References (54)

1. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
2. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166: 3789-3796. (Pubitemid 32224903)
3. Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
4. Belghith, M., J. A. Bluestone, S. Barriot, J. Megret, J. F. Bach, and L. Chatenoud. 2003. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9: 1202-1208. (Pubitemid 37173706)
5. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
6. Levings, M. K., R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M. G. Roncarolo. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166: 5530-5539. (Pubitemid 32374175)
7. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
8. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101: 4862-4869.
9. Bluestone, J. A. 2005. Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol. 5: 343-349.
10. Chaussabel, D., and J. Banchereau. 2005. Dendritic cells, therapeutic vectors of immunity and tolerance. Am. J. Transplant. 5: 205-206. (Pubitemid 40179506)
11. Korst, R. J., A. Mahtabifard, R. Yamada, and R. G. Crystal. 2002. Effect of adenovirus gene transfer vectors on the immunologic functions of mouse dendritic cells. Mol. Ther. 5: 307-315.
12. Follenzi, A., M. Battaglia, A. Lombardo, A. Annoni, M. G. Roncarolo, and L. Naldini. 2004. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103: 3700-3709.
13. Arai, T., M. Takada, M. Ui, and H. Iba. 1999. Dose-dependent transduction of vesicular stomatitis virus G protein- pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts. Virology 260: 109-115.
14. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258: 1156-1159.
15. Janssens, W., M. K. Chuah, L. Naldini, A. Follenzi, D. Collen, J. M. Saint-Remy, and T. VandenDriessche. 2003. Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent. Hum. Gene Ther. 14: 263-276.
16. Lei, T. C., and D. W. Scott. 2005. Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood 105: 4865-4870.
17. Wu, B., L. V. Elst, V. Carlier, M. G. Jacquemin, and J. M. Saint-Remy. 2002. The Dermatophagoides pteronyssinus group 2 allergen contains a universally immunogenic T cell epitope. J. Immunol. 169: 2430-2435.
18. Wu, B., G. Toussaint, L. Vander Elst, C. Granier, M. G. Jacquemin, and J. M. Saint-Remy. 2000. Major T cell epitope-containing peptides can elicit strong antibody responses. Eur. J. Immunol. 30: 291-299.
19. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62: 1120-1124.
20. Venditti, G., M. Di Ianni, F. Falzetti, L. Moretti, S. Di Florio, and A. Tabilio. 2003. NeoR-based transduced T lymphocytes detected by real-time quantitative polymerase chain reaction. J. Hematother. Stem Cell Res. 12: 83-91.
21. + T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J. Immunol. 171: 4604-4612.
22. Carlier, V. L., W. Janssens, M. G. Jacquemin, and J. M. R. Saint-Remy. 2007. Induction and efficacy of cytolytic regulatory T cells in experimental asthma. Allergy Clin. Immunol. Int. Suppl. 2.
23. Vanoirbeek, J. A., V. De Vooght, H. M. Vanhooren, T. S. Nawrot, B. Nemery, and P. H. Hoet. 2008. How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice? J. Allergy Clin. Immunol. 121: 456-463.
24. Wu, B., G. Toussaint, L. Vander Elst, C. Granier, M. G. Jacquemin, and J. M. Saint-Remy. 2000. Major T cell epitope-containing peptides can elicit strong antibody responses. Eur. J. Immunol. 30: 291-299.
25. Roncarolo, M. G., R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings. 2001. Type 1 T regulatory cells. Immunol. Rev. 182: 68-79.
26. Van Damme, A., L. Thorrez, L. Ma, H. Vandenburgh, J. Eyckmans, F. Dell'Accio, C. De Bari, F. Luyten, D. Lillicrap, D. Collen, et al. 2006. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 24: 896-907.
27. Litzinger, M. T., Y. Su, T. C. Lei, N. Soukhareva, and D. W. Scott. 2005. Mechanisms of gene therapy for tolerance: B7 signaling is required for peptide-IgG gene-transferred tolerance induction. J. Immunol. 175: 780-787.
28. Agarwal, R. K., Y. Kang, E. Zambidis, D. W. Scott, C. C. Chan, and R. R. Caspi. 2000. Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J. Clin. Invest. 106: 245-252.
29. Brown, B. D., G. Sitia, A. Annoni, E. Hauben, L. S. Sergi, A. Zingale, M. G. Roncarolo, L. G. Guidotti, and L. Naldini. 2007. In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 109: 2797-2805.
30. Forster, R., A. E. Mattis, E. Kremmer, E. Wolf, G. Brem, and M. Lipp. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87: 1037-1047.
31. Josephson, N. C., G. Vassilopoulos, G. D. Trobridge, G. V. Priestley, B. L. Wood, T. Papayannopoulou, and D. W. Russell. 2002. Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc. Natl. Acad. Sci. USA 99: 8295-8300.
32. + T regulatory cells and T regulatory type 1 cells. Diabetes 55: 1571-1580.
33. Bacchetta, R., M. Bigler, J. L. Touraine, R. Parkman, P. A. Tovo, J. Abrams, R. de Waal Malefyt, J. E. de Vries, and M. G. Roncarolo. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179: 493-502.
34. Akdis, C. A., T. Blesken, M. Akdis, B. Wuthrich, and K. Blaser. 1998. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102: 98-106.
35. + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J. Invest. Dermatol. 114: 295-302.
36. Battaglia, M., C. Gianfrani, S. Gregori, and M. G. Roncarolo. 2004. IL-10-producing T regulatory type 1 cells and oral tolerance. Ann. NY Acad. Sci. 1029: 142-153.
37. Cong, Y., C. T. Weaver, A. Lazenby, and C. O. Elson. 2002. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169: 6112-6119.
38. Zuany-Amorim, C., E. Sawicka, C. Manlius, A. Le Moine, L. R. Brunet, D. M. Kemeny, G. Bowen, G. Rook, and C. Walker. 2002. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8: 625-629.
39. Hussain, S., and T. L. Delovitch. 2007. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J. Immunol. 179: 7225-7232.
40. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
41. + T cells is induced by immunosuppressive drugs and inhibited by Th1- and Th2-inducing cytokines. Immunol. Lett. 85: 135-139.
42. Roncarolo, M. G., M. K. Levings, and C. Traversari. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193:F5-9, 2001.
43. + regulatory T cells and TGF-β? Gene Ther. 11: 1487-1496.
44. Chen, C. C., A. Rivera, J. P. Dougherty, and Y. Ron. 2004. Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen. Blood 103: 4616-4618.
45. Niimi, M., M. Hara, O. Witzke, P. J. Morris, and K. J. Wood. 1998. Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo. Transplantation 66: 1786-1792.
46. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
47. Melo, M. E., J. Qian, M. El-Amine, R. K. Agarwal, N. Soukhareva, Y. Kang, and D. W. Scott. 2002. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J. Immunol. 168: 4788-4795.
48. El-Amine, M., M. Melo, Y. Kang, H. Nguyen, J. Qian, and D. W. Scott. 2000. Mechanisms of tolerance induction by a gene-transferred peptide-IgG fusion protein expressed in B lineage cells. J. Immunol. 165: 5631-5636.
49. Eynon, E. E., and D. C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175: 131-138.
50. Chuah, M. K., G. Schiedner, L. Thorrez, B. Brown, M. Johnston, V. Gillijns, S. Hertel, N. Van Rooijen, D. Lillicrap, D. Collen, et al. 2003. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Blood 101:1734-1743.
51. Brown, B. D., A. Cantore, A. Annoni, L. Sergi Sergi, A. Lombardo, P. Della Valle, A. D'Angelo, and L. Naldini. 2007. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110: 4144-4152.
52. Brown, B. D., M. A. Venneri, A. Zingale, L. Sergi Sergi, and L. Naldini. 2006. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 12: 585-591.
53. Mingozzi, F., Y. L. Liu, E. Dobrzynski, A. Kaufhold, J. H. Liu, Y. Wang, V. R. Arruda, K. A. High, and R. W. Herzog. 2003. Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J. Clin. Invest. 111: 1347-1356.
54. Perreau, M., G. Pantaleo, and E. J. Kremer. 2008. Activation of a dendritic cell-T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells. J. Exp. Med. 205: 2717-2725.